<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

qz
Novo Nordisk is asking a court to immediately block Eli Lilly's weight loss drug ads

Novo says Lilly's ads for Zepbound and Mounjaro rely on outdated data and omit newer, higher-dose versions of Wegovy and Ozempic [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
NordVPN Review 2025: Innovative features, a few missteps

When we say that NordVPN is a good VPN that's not quite great, it's important to put that in perspective. Building a good VPN is hard, as evidenced by all the shovelware VPNs flooding the ma [...]

Match Score: 173.31

Destination
Surfshark VPN review: A fast VPN for casual users

Surfshark is one of the youngest major VPNs, but it's grown rapidly over the last seven years. Since 2018, it's expanded its network to 100 countries, added a suite of apps to its Surfshark [...]

Match Score: 173.29

Destination
ExpressVPN review 2025: Fast speeds and a low learning curve

ExpressVPN is good at its job. It's easy to be skeptical of any service with a knack for self-promotion, but don't let ExpressVPN's hype distract you from the fact that it keeps its fro [...]

Match Score: 169.13

Destination
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]

Match Score: 168.47

Destination
Proton VPN review 2025: A nonprofit service with premium performance

Proton VPN stands out for two main reasons: it's one of the only virtual private networks (VPNs) to include a free plan with no data limits, and it's one of the few services majority-owned b [...]

Match Score: 165.64

Destination
Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s drug came out on top.Read more... [...]

Match Score: 146.47

Destination
Eli Lilly and Novo Nordisk are tackling heart health next

After revolutionizing the weight-loss drug market, Novo Nordisk (NVO) and Eli Lilly (LLY) are setting their sights on heart health.Read more... [...]

Match Score: 125.95

thenextweb
Novo Nordisk’s owner backs an Italian fund to grow drug startups beyond Denmark

Novo Holdings, the investment company that controls Novo Nordisk and holds the wealth of the Novo Nordisk Foundation, is backing a fund aimed at Italian drug startups, according to Bloomberg. The mov [...]

Match Score: 98.19

qz
Novo Nordisk is suing Eli Lilly over ads it says mislead consumers on weight loss drug efficacy

Novo says Lilly's TV and social media campaigns cite outdated trial data to make Zepbound and Mounjaro look more effective than rival injections [...]

Match Score: 97.45